Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common / Ordinary Stock
-
Total 13F shares
-
4,317,596
-
Share change
-
-181,566
-
Total reported value
-
$156,142,037
-
Price per share
-
$36.16
-
Number of holders
-
67
-
Value change
-
-$6,612,632
-
Number of buys
-
32
-
Number of sells
-
22
Institutional Holders of Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) as of Q2 2022
As of 30 Jun 2022,
Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,317,596 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, Krensavage Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, BRANDES INVESTMENT PARTNERS, LP, ACADIAN ASSET MANAGEMENT LLC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, Eversept Partners, LP, Murchinson Ltd., BlackRock Inc., and ARMISTICE CAPITAL, LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.